Skip to main content
TipRanks
Go Ultimate75% OFF

InDex Pharmaceuticals Holding AB (1NP1) Q2 2023 Earnings Report

5 Followers

DE:1NP1 Q2 2023 EPS Results

Actual EPS
EUR 1.32
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.32

DE:1NP1 Q2 2023 Revenue Results

Actual Revenue
EUR 8.74M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2023
Date
08/23/2023
Time
TBA
Conference Call
Wednesday, August 23, 2023
DE:1NP1 Upcoming Earnings

InDex Pharmaceuticals Holding AB's next earnings date is estimated for January 20, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:1NP1 Earnings History

DE:1NP1 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Jan 20, 20272026 (Q4)―--0.55――
Oct 15, 20262026 (Q3)―-0.29-0.14-107.70% (-0.15)
Jul 09, 20262026 (Q2)―-0.090.17-152.29% (-0.27)
Apr 15, 20262026 (Q1)―-0.06-0.2575.76% (+0.19)
Jan 21, 20262025 (Q4)―-0.55-0.06-752.44% (-0.48)
Oct 22, 20252025 (Q3)―-0.14-0.12-18.75% (-0.02)
Jul 31, 20252025 (Q2)―0.1712.45-98.60% (-12.28)
Apr 16, 20252025 (Q1)―-0.25-0.04-469.43% (-0.21)
Jan 22, 20252024 (Q4)―-0.06-1.5595.86% (+1.49)
Oct 16, 20242024 (Q3)―-0.12-0.5678.94% (+0.44)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed